Filtered By:
Vaccination: Vaccines
This page shows you your search results in order of date. This is page number 7.
Order by Relevance | Date
Total 39664 results found since Jan 2013.
Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults
ConclusionsBNT162b2 coadministered with SIIV elicited immune responses that were noninferior to those elicited by BNT162b2 alone and SIIV alone, and BNT162b2 had an acceptable safety profile when coadministered with SIIV. The results of this study support the coadministration of BNT162b2 and SIIV in adults.Trial RegistrationClinicalTrials.gov registration: NCT05310084.
Source: Infectious Diseases and Therapy - September 12, 2023 Category: Infectious Diseases Source Type: research
Factors influencing the perception and the willingness to take the COVID-19 vaccine among the working population in Ghana
Frank Gyimah Sackey, Richard Asravor, Christopher Lamptey Journal of Integrated Care, Vol. ahead-of-print, No. ahead-of-print, pp.- The onset of the coronavirus disease 2019 (COVID-19) has led to loss of lives and jobs and other adverse effects on persons, families and businesses. With its frightening tendencies, it was a sigh of relief with the discovery of vaccines to mitigate its disastrous effects. However, participation in the vaccination exercise in Ghana has been slow and unencoraging. This paper sought to identify the factors that influence the perception and willingness of individuals to receive the COVID-19 vacc...
Source: Journal of Integrated Care - September 11, 2023 Category: International Medicine & Public Health Authors: Frank Gyimah Sackey Richard Asravor Christopher Lamptey Source Type: research
The FDA Approves New COVID-19 Vaccine Booster Shots To Protect Against Recent Strains
WASHINGTON (AP) — The U.S. approved updated COVID-19 vaccines Monday, hoping to rev up protection against the latest coronavirus strains and blunt any surge this fall and winter.
The Food and Drug Administration decision opens the newest shots from Moderna and Pfizer and its partner BioNTech to most Americans even if they’ve never had a coronavirus vaccination. It’s part of a shift to treat fall updates of the COVID-19 vaccine much like getting a yearly flu shot.
[time-brightcove not-tgx=”true”]
There’s still another step: The Centers for Disease Control and Prevention m...
Source: TIME: Health - September 11, 2023 Category: Consumer Health News Authors: LAURAN NEERGAARD / AP Tags: Uncategorized COVID-19 wire Source Type: news
FDA okays new coronavirus vaccine as respiratory illness season nears
The covid vaccines are expected to be available later this week after the Centers for Disease Control and Prevention signs off.
Source: Washington Post: To Your Health - September 11, 2023 Category: Consumer Health News Authors: Laurie McGinley Source Type: news
FDA Approves New Covid Vaccines To Target Latest Strains
The Food and Drug Administration gave its approval for emergency use Monday to new updated Covid-19 vaccines from Pfizer-BioNTech and Moderna that are specially designed to protect against the latest dominant strain of the coronavirus.
Source: Forbes.com Healthcare News - September 11, 2023 Category: Pharmaceuticals Tags: Business /business Healthcare /healthcare Source Type: news
New coronavirus vaccine shots are on the way. Here’s what to know.
The new coronavirus shots are designed to provide improved protection against omicron subvariants now in circulation.
Source: Washington Post: To Your Health - September 11, 2023 Category: Consumer Health News Authors: Laurie McGinley Source Type: news
FDA authorizes updated Covid-19 vaccines, with CDC sign-off to come soon
The new vaccines are designed to target the coronavirus' XBB.1.5 lineage, a descendant of the omicron variant that closely matches currently circulating forms of the virus.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 11, 2023 Category: Pharmaceuticals Authors: Rowan Walrath Source Type: news
F.D.A. Approves New Covid Shots
A nationwide rollout of the vaccines by Pfizer and Moderna should begin later this week, after the C.D.C. considers guidelines to prepare Americans for this season when infections usually tick upward.
Source: NYT Health - September 11, 2023 Category: Consumer Health News Authors: Christina Jewett and Noah Weiland Tags: Drugs (Pharmaceuticals) Vaccination and Immunization Coronavirus (2019-nCoV) Deaths (Fatalities) Influenza Elderly Health Insurance and Managed Care Respiratory Syncytial Virus (RSV) Coronavirus Omicron Variant Immune System BioNTech S Source Type: news
US approves updated COVID vaccines to rev up protection this fall
The U.S. approved updated COVID-19 vaccines Monday, hoping to rev up protection against the latest coronavirus strains and blunt any surge this fall and winter. The Food and Drug Administration decision opens the newest shots from Moderna and Pfizer and its partner BioNTech to most Americans even…#moderna #pfizer #cdc #fda
Source: Reuters: Health - September 11, 2023 Category: Consumer Health News Source Type: news
Evaluation of Safety and Immunogenicity of a SARS-CoV-2(Severe Acute Respiratory Syndrome Coronavirus 2) Booster Vaccine (LEM-mR203)
Conditions: COVID-19 Infection; COVID-19 Vaccine Adverse Reaction Interventions: Biological: LEM-mR203; Biological: Placebo Sponsor: Lemonex Not yet recruiting
Source: ClinicalTrials.gov - September 11, 2023 Category: Research Source Type: clinical trials
